Abstract
High levels of circulating carotenoids are hypothesized to reduce breast cancer risk, potentially due to their antioxidant properties. However, little is known about the relationship between carotenoid exposure earlier in life and risk. We examined associations of premenopausal plasma carotenoids and markers of oxidative stress and risk of breast cancer among 1179 case–control pairs in the Nurses’ Health Study (NHS) and NHSII. Levels of α- and β-carotene, β-cryptoxanthin, lycopene, and lutein/zeaxanthin were quantified by high-performance liquid chromatography. Three fluorescent oxidation products (FlOP_360, FlOP_320, FlOP_400) were measured in a subset of participants by spectrofluoroscopy. Multivariate conditional logistic regression was used to estimate odds ratios and 95 % confidence intervals for breast cancer by quartile, as well as P values for tests of linear trend. We additionally examined whether 45 single-nucleotide polymorphisms (SNPs) in five genes involved in oxidative and antioxidative processes or carotenoid availability were associated with risk. Carotenoid measures were not inversely associated with breast cancer risk. No differences by estrogen receptor status were observed, though some inverse associations were observed among women postmenopausal at diagnosis. Plasma FlOP levels were not positively associated with risk, and suggestive inverse associations with FlOP_320 and FlOP_360 were observed. Several SNPs were associated with carotenoid levels, and a small number were suggestively associated with breast cancer risk. We observed evidence of interactions between some SNPs and carotenoid levels on risk. We did not observe consistent associations between circulating levels of premenopausal carotenoids or FlOP levels and breast cancer risk.
Similar content being viewed by others
References
Van Gils CH et al (2005) Consumption of vegetables and fruits and risk of breast cancer. JAMA, J Am Med Assoc 293:183–193
Lissowska J et al (2008) Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status. Breast Cancer Res Treat 107:113–117
Jung S et al (2013) Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst 105:219–236
Smith-Warner SA et al (2001) Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA 285:769–776
Aune D et al (2012) Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat 134:479–493
Toniolo P et al (2001) Serum carotenoids and breast cancer. Am J Epidemiol 153:1142–1147
Dorjgochoo T et al (2009) Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS). Breast Cancer Res Treat 117:381–389
Kabat GC et al (2009) Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women. Am J Clin Nutr 90:162–169
Epplein M et al (2009) Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control study. Breast Cancer Res. BCR 11:R49
Tamimi RM et al (2005) Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161:153–160
Sato R et al (2002) Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomark Prev 11:451–457
Maillard V et al (2010) Serum carotenoid, tocopherol and retinol concentrations and breast cancer risk in the E3 N-EPIC study. J Int Cancer 127:1188–1196
Aune D et al (2012) Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 96:356–373
Mignone LI et al (2009) Dietary carotenoids and the risk of invasive breast cancer. Int J Cancer 124:2929–2937
Nagel G et al (2010) Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Breast Cancer Res Treat 119:753–765
Zhang X et al (2012) Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr 95:713–725
Eliassen AH et al (2012) Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst 104:1905–1916
Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267
Dai Q et al (2009) Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women’s Health Study. J Clin Oncol 27:2482–2488
Lee K-H et al (2010) Breast cancer and urinary biomarkers of polycyclic aromatic hydrocarbon and oxidative stress in the Shanghai Women’s Health Study. Cancer Epidemiol Biomark Prev 19:877–883
Fortner RT, Tworoger SS, Wu T, Eliassen AH (2013) Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses’ Health Study. Breast Cancer Res Treat 141:307–316
Hankinson SE et al (1995) Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 87:1297–1302
Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66:2476–2482
Eliassen AH et al (2014) Plasma carotenoids and risk of breast cancer over 20 years of follow-up. Am J Clin Nutr 74:2919
El-Sohemy A et al (2002) Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. Am J Clin Nutr 76:172–179
Wu T, Rifai N, Roberts LJ 2nd, Willett WC, Rimm EB (2004) Stability of measurements of biomarkers of oxidative stress in blood over 36 h. Cancer Epidemiol Biomark Prev 13:1399–1402
Rosner B, Cook N, Portman R, Daniels S, Falkner B (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167:653–666
De Bakker PIW et al (2005) Efficiency and power in genetic association studies. Nat Genet 37:1217–1223
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
Ambrosone CB (2000) Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2:903–917
Lietz G, Lange J, Rimbach G (2010) Molecular and dietary regulation of beta, beta-carotene 15,15′-monooxygenase 1 (BCMO1). Arch Biochem Biophys 502:8–16
Hendrickson SJ et al (2013) Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomark Prev 22:927–936
Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165–172
Marshall RJ, Chisholm EM (1985) Hypothesis testing in the polychotomous logistic model with an application to detecting gastrointestinal cancer. Stat Med 4:337–344
Hendrickson SJ et al (2012) β-Carotene 15,15′-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent. Am J Clin Nutr 96:1379–1389
Frei B (1994) Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 97, 5S–13S; discussion 22S–28S
Wu T, Willett WC, Rifai N, Rimm EB (2007) Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies. Am J Epidemiol 166:552–560
Jensen MK et al (2013) Fluorescent oxidation products and risk of coronary heart disease: a prospective study in women. J Am Heart Assoc 2:e000195
Wu T, Rifai N, Willett WC, Rimm EB (2007) Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men. Am J Epidemiol 166:544–551
Wang S et al (2009) Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk—A meta-analysis. Eur J Cancer 1990(45):2874–2881
Tong S-Y et al (2009) Functional polymorphism in manganese superoxide dismutase and antioxidant status: their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer. Gynecol Oncol 115:272–276
Mikhak B et al (2008) Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 29:2335–2340
Ahn J et al (2006) Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomark Prev 15:1217–1222
Nadif R et al (2005) Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res 39:1345–1350
Bastaki M et al (2006) Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics 16:279–286
Ahn J et al (2005) Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 162:943–952
Quick SK et al (2008) Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol Biomark Prev 17:1082–1087
Lietz G, Oxley A, Leung W, Hesketh J (2012) Single nucleotide polymorphisms upstream from the β-carotene 15,15′-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr 142:161S–165S
Leung WC et al (2009) Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15′-monoxygenase alter beta-carotene metabolism in female volunteers. FASEB J 23:1041–1053
Ferrucci L et al (2009) Common variation in the beta-carotene 15,15′-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet 84:123–133
Kotsopoulos J et al (2010) Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses’ Health Studies. Cancer Epidemiol Biomark Pre 19:938–946
Acknowledgments
We would like to thank the participants and staff of the Nurses Health Study and NHSII for their valuable contributions as well as the following state cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, and WY. The authors assume full responsibility for analyses and interpretation of these data.
Conflict of interest
None.
Funding/support
This study was supported in part by R01 CA050385 (Walter Willett, PI) and UM1 CA176726 (Willett, PI). This project was additionally supported in part by UM1 CA186107, P01 CA87969, R01 CA49449, and R01 CA67262. Julia Sisti was supported by training Grants R25 CA098566 and T32 CA900137.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sisti, J.S., Lindström, S., Kraft, P. et al. Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses’ health studies. Breast Cancer Res Treat 151, 415–425 (2015). https://doi.org/10.1007/s10549-015-3391-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-015-3391-6